OnCo
frontsFront

Chemotherapy

Drugs that kill fast-dividing cells. Still the backbone of many cures, and now the warhead inside smarter drugs.

Cytotoxics (platinums, taxanes, anthracyclines, antimetabolites, topoisomerase inhibitors) remain curative in several cancers and are the payloads of antibody-drug conjugates. Progress is in dosing, sequencing, biomarker-guided de-escalation, and toxicity mitigation.

Chemotherapy: how this front works · animated schematic, not to scale

Technologies

16top
Standard of care
Autologous stem cell transplant (high-dose therapy)

Collect the patient's own blood-forming stem cells, give a very high dose of chemotherapy that would otherwise destroy the marrow, then give the cells back to rebuild it.

Phase 2
Chronotherapy: timing treatment to the body clock

Giving the same drug at a different time of day, because the body clock changes how much damage it does and how well the immune system responds.

Standard of care
Cytotoxic chemotherapy

Cytotoxic chemotherapy drugs kill rapidly dividing cells. They are still curative in testicular cancer, lymphoma, leukaemia, and many early-stage cancers, and they are the warhead inside ADCs.

Established
Exercise during chemotherapy and radiotherapy

Moderate exercise while on chemotherapy is safe and reduces fatigue, helps people finish their planned doses, and may protect the heart and nerves.

Phase 2
Fasting and fasting-mimicking diets around chemotherapy

Eating very little for a few days around each chemotherapy dose might protect normal cells and sensitise the tumour. Early trials are intriguing but small, and it is not something to try without a dietitian.

Established
Generic oncology drug supply and shortage mitigation

Keeping cheap, essential chemotherapy drugs like cisplatin available; shortages in 2023 forced rationing in US hospitals.

Established
HIPEC / PIPAC (intraperitoneal chemotherapy)

Washing the abdominal cavity with heated chemotherapy during surgery to kill microscopic peritoneal deposits.

Phase 2
Hypoxia-activated prodrugs

A harmless molecule that turns into a poison only where there is no oxygen, which in the body means inside a tumour.

Standard of care
Infusion pumps, ports, and ambulatory chemotherapy devices

Infusion devices are the implanted ports, smart pumps, and take-home pumps that deliver chemotherapy safely, including 46-hour infusions patients carry home.

Phase 2
Metabolic therapy: starving the tumour of a nutrient

Removing an amino acid or nutrient that certain tumours cannot make for themselves, while normal cells can.

Established
Oncology pharmacy automation and compounding robots

Robots and closed systems that prepare chemotherapy doses safely, protecting pharmacists from hazardous drugs and patients from errors.

Standard of care
PET-adapted (response-adapted) therapy

Scan after two cycles of chemotherapy; if the tumour has gone dark, give less treatment, and if not, give more. Hodgkin lymphoma pioneered this.

Standard of care
Platinum agents

Platinum agents such as cisplatin and carboplatin work by crosslinking DNA. They are curative in testicular cancer and central to lung, ovarian, bladder, head and neck, and TNBC treatment.

Standard of care
Tandem autologous transplant

Two rounds of very high-dose chemotherapy with stem-cell rescue, back to back, used in high-risk neuroblastoma in North America.

Standard of care
Topoisomerase-I inhibitors (and ADC payloads)

Topoisomerase-I inhibitors work by jamming the enzyme that untangles DNA during copying. They are weak as free drugs in many cancers, but devastating when delivered by an ADC.

Standard of care
Transarterial chemoembolisation (TACE)

A catheter threaded into the artery feeding a liver tumour delivers chemotherapy and then blocks the vessel, starving the tumour from inside.

Key papers

1top

Connected

59top

technologies

16

companies

7

institutions

22

terms

1

ideas

5

people

7

key papers

1